Most Popular
-
6
[Graphic News] More Koreans say they plan long-distance trips this year
![[Graphic News] More Koreans say they plan long-distance trips this year](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/17/20240417050828_0.gif&u=)
-
7
[KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs
![[KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/18/20240418050645_0.jpg&u=20240419100350)
-
8
North Korea removes streetlights along cross-border roads with South
-
9
Russia's denial of entry of S. Korean national unrelated to bilateral ties: Seoul official
-
10
Farming households dip below 1m for first time in 2023
![[Graphic News] More Koreans say they plan long-distance trips this year](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/17/20240417050828_0.gif&u=)
![[KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/18/20240418050645_0.jpg&u=20240419100350)
[THE INVESTOR] Boryung Pharmaceutical on June 20 clinched a deal with Sandoz, the generic division of Swiss drug maker Novartis, to export its anti-hypertension drug Cilnidipine to Southeast Asian countries.
Under the contract, Boryung will provide US$ 73 million worth of drugs through Sandoz to six countries, including Thailand, Philippines, Malaysia, Singapore, Taiwan and Hong Kong over the 10 year period.
“Based on the experience from Knarb’s marketing abroad, we will increase our brand’s value in the anti-hypertension market in Southeast Asian countries,” Choi Tae-hong, CEO of Boryung said.
By Ahn Sung-mi (sahn@heraldcorp.com)
Under the contract, Boryung will provide US$ 73 million worth of drugs through Sandoz to six countries, including Thailand, Philippines, Malaysia, Singapore, Taiwan and Hong Kong over the 10 year period.
“Based on the experience from Knarb’s marketing abroad, we will increase our brand’s value in the anti-hypertension market in Southeast Asian countries,” Choi Tae-hong, CEO of Boryung said.
By Ahn Sung-mi (sahn@heraldcorp.com)
![[From the Scene] Monks, Buddhists hail return of remains of Buddhas](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/04/19/20240419050617_0.jpg&u=20240419175937)
![[KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/04/18/20240418050645_0.jpg&u=20240419100350)
![[Today’s K-pop] Illit drops debut single remix](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/04/19/20240419050612_0.jpg&u=)